The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
Animal models of multiple sclerosis (MS) have been extensively used to characterize the disease mechanisms in MS, as well as to identify potential pharmacologic targets for this condition. In recent years, the immune complement system has gained increased attention as an important effector in the pa...
Main Authors: | Nil Saez-Calveras, Amy L. Brewster, Olaf Stuve |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2022.1017484/full |
Similar Items
-
The role of the complement system in Multiple Sclerosis: A review
by: Nil Saez-Calveras, et al.
Published: (2022-08-01) -
Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models
by: Maria Concetta Geloso, et al.
Published: (2021-03-01) -
Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure
by: Navid Manouchehri, et al.
Published: (2022-03-01) -
Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
by: Marina Boziki, et al.
Published: (2023-01-01) -
Editorial: Animal models of multiple sclerosis: can they advance future therapies?
by: Tara Maria DeSilva, et al.
Published: (2023-06-01)